Onivyde (irinotecan liposome)

pCPA File Number: 22472
Negotiation Status:
Concluded without agreement
Indication(s):
Metastatic Pancreatic Cancer
Sponsor/Manufacturer:
Ipsen Biopharmaceuticals Canada, Inc.
CDA-AMC Project Number:
Not Applicable
pCPA Engagement Letter Issued:
Negotiation Process Concluded: